Journal List > J Korean Soc Radiol > v.78(2) > 1095560

This article has been corrected. See "Korean Clinical Imaging Guideline for Hemoptysis" in Volume 78 on page 299.
Kang, Kim, Kim, Lee, Shin, Kim, Lee, Do, Yong, Choi, Choi, and Jung: Korean Clinical Imaging Guideline for Hemoptysis

Abstract

In 2014, the American College of Radiology announced a guideline for appropriate diagnostic approach and treatment in patients with hemoptysis, according to severity of hemoptysis and risk of lung cancer. However, in Korea many patients have pulmonary fibrosis due to previous tuberculosis or have active tuberculosis. Therefore, application of this guideline is not appropriate. The Korean Society of Radiology and Korean Society of Thoracic Radiology proposed a guideline more closely matching the real state of diagnostic approach and treatment of patients with hemoptysis in Korea. The guideline was prepared in consensus by a development committee, working party, and an advisory committee. The process of the guideline proposal was based on methodology for developing evidence-based clinical imaging guidelines: joint recommendations by the Korean Society of Radiology and National Evidence-Based Healthcare Collaborating Agency. The clinical imaging guideline for adult patients with hemoptysis is as follows. Chest radiography is an initial imaging modality to evaluate hemoptysis. Contrast enhanced chest CT is recommended in patients with two lung cancer risks (> 40 years old and > 30 packs per year smoking history), moderate hemoptysis (> 30 cc/24 hours) or recurrent hemoptysis. Contrast enhanced chest CT is also recommended for patients with massive hemoptysis (> 400 mL/24 hours) without cardiopulmonary compromise.

References

1. ACR Appropriateness Criteria® hemoptysis. Available at:. https://acsearch.acr.org/docs/69449/Narrative/. Published. Aug, 2010. Accessed Jan 31, 2017.
2. Choi SJ, Jeong WK, Jo AJ, Choi JA, Kim MJ, Lee M, et al. Methodology for developing evidence-based clinical imaging guidelines: joint recommendations by Korean Society of Radiology and National Evidence-Based Healthcare Collaborating Agency. Korean J Radiol. 2017; 18:208–216.
crossref
3. Tsoumakidou M, Chrysofakis G, Tsiligianni I, Maltezakis G, Siafakas NM, Tzanakis N. A prospective analysis of 184 hemoptysis cases: diagnostic impact of chest X-ray, computed tomography, bronchoscopy. Respiration. 2006; 73:808–814.
4. Fidan A, Ozdog˘an S, Oruç O, Salepçi B, Ocal Z, Cag˘layan B. Hemoptysis: a retrospective analysis of 108 cases. Respir Med. 2002; 96:677–680.
crossref
5. Bruzzi JF, Rémy-Jardin M, Delhaye D, Teisseire A, Khalil C, Rémy J. Multi-detector row CT of hemoptysis. Radiographics. 2006; 26:3–22.
crossref
6. Lee SJ, Rho JY, Yoo SM, Kim MD, Lee JH, Kim EK, et al. Usefulness of multi-detector computed tomography before bronchoscopy and/or bronchial arterial embolization for hemoptysis. Tuberc Respir Dis. 2010; 68:80–86.
crossref
7. Revel MP, Fournier LS, Hennebicque AS, Cuenod CA, Meyer G, Reynaud P, et al. Can CT replace bronchoscopy in the detection of the site and cause of bleeding in patients with large or massive hemoptysis? AJR Am J Roentgenol. 2002; 179:1217–1224.
8. Delage A, Tillie-Leblond I, Cavestri B, Wallaert B, Marquette CH. Cryptogenic hemoptysis in chronic obstructive pulmonary disease: characteristics and outcome. Respiration. 2010; 80:387–392.
crossref
9. Menchini L, Remy-Jardin M, Faivre JB, Copin MC, Ramon P, Matran R, et al. Cryptogenic haemoptysis in smokers: angiography and results of embolisation in 35 patients. Eur Respir J. 2009; 34:1031–1039.
crossref
10. Poe RH, Israel RH, Marin MG, Ortiz CR, Dale RC, Wahl GW, et al. Utility of fiberoptic bronchoscopy in patients with hemoptysis and a nonlocalizing chest roentgenogram. Chest. 1988; 93:70–75.
crossref
11. Herth F, Ernst A, Becker HD. Long-term outcome and lung cancer incidence in patients with hemoptysis of unknown origin. Chest. 2001; 120:1592–1594.
crossref
12. Thirumaran M, Sundar R, Sutcliffe IM, Currie DC. Is investigation of patients with haemoptysis and normal chest radiograph justified? Thorax. 2009; 64:854–856.
13. McGuinness G, Beacher JR, Harkin TJ, Garay SM, Rom WN, Naidich DP. Hemoptysis: prospective high-resolution CT/bronchoscopic correlation. Chest. 1994; 105:1155–1162.
crossref
14. Kim HB. Bronchial artery embolization. Korean Society of Interventional Radiology. ed.Interventional radiology. 2nd ed.Seoul: Ilchokak;2014. p. 321–325.
15. Millar AB, Boothroyd AE, Edwards D, Hetzel MR. The role of computed tomography (CT) in the investigation of unexplained haemoptysis. Respir Med. 1992; 86:39–44.
16. Khalil A, Fartoukh M, Parrot A, Bazelly B, Marsault C, Carette MF. Impact of MDCT angiography on the management of patients with hemoptysis. AJR Am J Roentgenol. 2010; 195:772–778.
crossref
17. Hsiao EI, Kirsch CM, Kagawa FT, Wehner JH, Jensen WA, Baxter RB. Utility of fiberoptic bronchoscopy before bronchial artery embolization for massive hemoptysis. AJR Am J Roentgenol. 2001; 177:861–867.
crossref

Fig. 1.
Flow chart for literature selection. GIN = Guideline International Network, I = intervention/index test, KCIG = Korean Clinical Imaging Guidelines, NGC = National Guideline Clearinghouse, O = outcome, P = population/patient
jksr-78-81f1.tif
Table 1.
AGREE II
Source of Recommendation AGREE II Score Proposal of Develomental Committee
ACR Appropriateness Criteria® hemoptysis. 66 Recommended

Not recommended: AGREE score < 50.

ACR = American College of Radiology, AGREE = Appraisal of Guidelines for Research & Evaluation

Table 2.
Criteria for Evidence Level of Each Evidence Literatures
Level Content
1 Research satisfying all of criteria following three
    1) Good reference standard
    2) Consecutive patients study
    3) Blind interpretation
  Systematic review of level 1
  Randomized controlled trial or cross-sectional cohort study that compares index test to comparators
2 Research satisfying all of criteria following two
    1) Good reference standard
    2) Consecutive patients study or blind interpretation
  Systematic review of level 2
  Observational studies that compares index test to comparators
3 Without consistently applied reference standards
4 Case-control study
  Poor or non-independent reference standard
5 Expert opinion

Adated from Choi SJ et al. Korean J Radiol 2017;18:208–216 (2)

Table 3.
Grades of Korean Clinical Imaging Guidelines Recommendation
Grading Content Meaning
A Recommended This intervention (examination) has enough evidence to support desired effect, and therefore, is recommended
B (Conditional) recommended This intervention (examination) has intermediate to enough level of evidence to support desired effect
    Provide intervention (examination) selectively, or for specific individuals based on expert's judgment
C Not recommended This intervention (examination) has enough evidence to support non-desired effect, and therefore,
    is not recommended (use of this examination is not recommended)
D No recommendation This intervention (examination) does not have enough evidence to either support or reject effectiveness, and
    needs further research
    This intervention (examination) has very low level of certainty for desired effect, and decision based on recommendation grading has no meaning

Adated from Choi SJ et al. Korean J Radiol 2017;18:208–216 (2)

Table 4.
Korean Relative Radiation Level
jksr-78-81f2.tif
Supplementary Table 1
Evidence Table
Literatures Research Type Number of Enrolled Patients Evidence Level
Tsoumakidou M, Chrysofakis G, Tsiligianni I, Maltezakis G, Siafakas NM, Tzanakis N. Observational (retrospective)_Dx 184 2
A prospective analysis of 184 hemoptysis cases: diagnostic impact of chest X-ray,      
computed tomography, bronchoscopy. Respiration 2006;73(6):808–814.      
Fidan A, Ozdog˘an S, Oruç O, Salepçi B, Ocal Z, Cag˘layan B. Hemoptysis: Observational (prospective)_Dx 108 2
a retrospective analysis of 108 cases. Respir Med 2002;96(9):677–680.      
Bruzzi JF, Rémy-Jardin M, Delhaye D, Teisseire A, Khalil C, Rémy J. Review/other-Dx N/A 2
Multi-detector row CT of hemoptysis. Radiographics 2006;26(1):3–22.      
Ketai LH, Mohammed TL, Kirsch J, et al. ACR appropriateness criteria® hemoptysis. Review/other-Dx N/A 2
J Thorac Imaging 2014;29(3):W19-W22.      
Lee SJ, Rho JY, Yoo SM, et al. Usefulness of multi-detector computed tomography Observational (prospective)_Dx 125 2
before bronchoscopy and/or bronchial arterial embolization for hemoptysis.      
Tuberc Respir Dis 2010;68(2):80–86.      
Revel MP, Fournier LS, Hennebicque AS, et al. Can CT replace bronchoscopy in the Observational-Dx 80 3
detection of the site and cause of bleeding in patients with large or massive      
hemoptysis? AJR Am J Roentgenol 2002;179(5):1217–1224.      
Delage A, Tillie-Leblond I, Cavestri B, Wallaert B, Marquette CH. Cryptogenic Observational-Dx 39 3
hemoptysis in chronic obstructive pulmonary disease: characteristics      
and outcome. Respiration 2010;80(5):387–392.      
Menchini L, Remy-Jardin M, Faivre JB, et al. Cryptogenic haemoptysis in smokers: Observational-Dx 35 3
angiography and results of embolisation in 35 patients. Eur Respir J 2009;34(5):      
1031–1039.      
Poe RH, Israel RH, Marin MG, et al. Utility of fiberoptic bronchoscopy in patients Observational-Dx 196 4
with hemoptysis and a nonlocalizing chest roentgenogram. Chest 1988;93(1):      
70–75.      
Herth F, Ernst A, Becker HD. Long-term outcome and lung cancer incidence Review/other-Dx 722 4
in patients with hemoptysis of unknown origin. Chest 2001;120(5):1592–1594.      
Thirumaran M, Sundar R, Sutcliffe IM, Currie DC. Is investigation of patients with Observational-Dx 270 2
haemoptysis and normal chest radiograph justified? Thorax 2009;64(10):854–856.      
McGuinness G, Beacher JR, Harkin TJ, Garay SM, Rom WN, Naidich DP. Observational-Dx 57 2
Hemoptysis: prospective high-resolution CT/bronchoscopic correlation.      
Chest 1994;105(4):1155–1162.      
Millar AB, Boothroyd AE, Edwards D, Hetzel MR. The role of computed Review/other-Dx 40 4
tomography (CT) in the investigation of unexplained haemoptysis. Respir Med      
1992;86(1):39–44.      
Khalil A, Fartoukh M, Parrot A, Bazelly B, Marsault C, Carette MF. Impact of MDCT Observational-Dx 400 3
angiography on the management of patients with hemoptysis. AJR Am J      
Roentgenol 2010;195(3):772–778.      
Hsiao EI, Kirsch CM, Kagawa FT, Wehner JH, Jensen WA, Baxter RB. Review/other-Dx 28 3
Utility of fiberoptic bronchoscopy before bronchial artery embolization for      
massive hemoptysis. AJR Am J Roentgenol 2001;177(4):861–867.      

Dx = diagnosis

TOOLS
Similar articles